Can metoprolol and mitotane be taken together?

In the treatment of adrenocortical cancer (Adrenal cancer) and accompanying diseases, patients often need to manage blood pressure or heart disease at the same time, and metoprolol is a commonly used β1 receptor blockers are widely used in patients with hypertension or arrhythmia. Therefore, many patients and clinicians are concerned about whether mitotane and metoprolol can be taken together.

Mitotane (Mitotane) is a fat-soluble oral anti-tumor drug that is mainly metabolized in the liver through CYP3A4 . Metoprolol is also excreted through the liver metabolism pathway. Therefore, there is a theoretical risk of drug interaction, which may cause fluctuations in blood drug concentration and affect efficacy or tolerability. Clinical experience shows that if the two drugs are used at the same time, heart rate, blood pressure and liver function indicators need to be closely monitored, and attention should be paid to the dyslipidemia and neurological adverse reactions that mitotane may cause. These factors may indirectly affect the efficacy or tolerability of metoprolol.

If necessary, they can be used together under the guidance of a doctor, but the dosage needs to be adjusted, the monitoring interval extended, and the occurrence of adverse reactions needs to be observed. In addition, mitotane may affect the activity of hepatic enzymes. Special attention should be paid to metoprolol plasma levels during long-term high-dose use to avoid risks such as bradycardia or hypotension. When using two drugs at the same time, patients should also avoid adding other drugs or herbal supplements that may affect CYP3A4 metabolism, as this may increase toxicity or weaken efficacy.

In general, metoprolol and mitotane can be taken together under strict monitoring and individualized adjustments, but patients must do so under the guidance of a professional doctor and undergo regular blood pressure, heart rate and laboratory tests to ensure the safety and effectiveness of the treatment, while maintaining the continuity of disease management and quality of life.

References: https://go.drugbank.com/drugs/DB00648